28 November 2019

Bart-Jan Kullberg and Jacques Meis, made it to this year’s list of highly cited researchers. Researchers in this list are selected for their exceptional research performance and are regarded to have had a major impact on fellow scientists.

The list was recently published by the Web of Science Group. According to the creator of the list, the awarded researchers ‘have demonstrated significant influence through publication of multiple highly cited papers during the last decade’.

We congratulate Bart-Jan Kullberg (Cross-Field) and Jacques Meis (Cross-Field).

Related news items


Q fever antibody does not predict disease progression

6 July 2021

Joint study by Radboudumc, Jeroen Bosch Hospital and UMC Utrecht.

read more

First Dutch professor of infectious disease outbreaks at Radboud university medical center

4 June 2021

Chantal Bleeker-Rovers about research on coronavirus, Q fever and other infectious diseases outbreaks

read more

First volunteers vaccinated with Radboudumc malaria vaccine

20 May 2021

Today a new vaccine against malaria, largely developed in Nijmegen, is being tested for the first time in volunteers at Radboudumc.

read more

Chronic malaria infections produce more and more infectious gametocytes

28 April 2021

In a recent article in Nature Communications, researchers from the department of Medical Microbiology uncovered intriguing dynamics in the production of the transmission stages of malaria parasites, gametocytes.

read more

Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection

17 February 2021

In a review in Cell Mihai Netea, Frank van de Veerdonk, Reinout van Crevel and Jorge Dominguez Andres propose that induction of trained immunity by whole-microorganism vaccines may represent an important tool for reducing susceptibility to and severity of SARS-CoV-2.

read more

Invasive fungal infections in influenza and COVID-19

8 July 2020

The Aspergillus fungus is found in the lungs of many COVID patients. A parallel occurs with influenza patients, who often develop a serious fungal infection. Although such a serious fungal infection seems to occur less frequently in COVID-patients, alertness remains necessary,

read more